OSMR: Modulating Protein Activity AndRegulation of Cellular Processes
OSMR: Modulating Protein Activity AndRegulation of Cellular Processes
Oncostatin-M Receptor (OSMR) is a protein that is expressed in various tissues throughout the body. It is a G protein-coupled receptor (GPCR), which means it has a transmembrane interface that is covered with a protein called transmembrane domain. This protein plays a crucial role in many cellular processes in the body, including signaling pathways that regulate cell growth, differentiation, and inflammation.
One of the unique features of OSMR is its ability to modulate the activity of other proteins. This is accomplished through a process called phosphorylation, which involves the addition of a phosphate group to a specific amino acid residue on the protein. This modification can have a significant impact on the function of the OSMR, and research has shown that it can play a role in a wide range of biological processes.
One of the key diseases that is associated with changes in OSMR activity is cancer. Cancer cells often have increased activity in OSMR, which allows them to grow and divide more efficiently. This is because OSMR signaling pathways are often activated in these cells, which allows them to access the resources they need for growth and division.
Another promising aspect of OSMR research is its potential as a drug target. By targeting OSMR with small molecules or other compounds, researchers can inhibit its activity and potentially disrupt the signaling pathways that are associated with cancer. This has the potential to be a valuable tool for the development of new cancer therapies.
OSMR has also been shown to play a role in the regulation of inflammation. Many diseases, including chronic obstructive pulmonary disease (COPD), are associated with chronic inflammation. OSMR has been shown to be involved in the regulation of this inflammation, and research has shown that inhibiting its activity may be a potential therapy for these diseases.
In addition to its potential as a drug target, OSMR is also of interest to researchers because of its unique structure and function. The transmembrane domain of OSMR is composed of a series of conserved amino acids that are involved in the formation of a highly conserved hydrophobic region. This region is thought to play a key role in the stability and activity of the OSMR protein.
Research has also shown that OSMR is involved in many different signaling pathways in the body. This includes the regulation of cell adhesion, cell migration, and the production of various signaling molecules. This suggests that OSMR is involved in a wide range of cellular processes that are important for the health and survival of the body.
Overall, Oncostatin-M Receptor (OSMR) is a protein that is widely expressed in various tissues throughout the body and is involved in many different signaling pathways. Its unique structure and function make it an attractive target for research and potential therapeutic applications. Further research is needed to fully understand the role of OSMR in the regulation of cellular processes and its potential as a drug target.
Protein Name: Oncostatin-M Receptor
The "Oncostatin-M Receptor Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Oncostatin-M Receptor comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
ONECUT1 | ONECUT2 | ONECUT3 | OOEP | OOSP1 | OOSP2 | OPA1 | OPA1-AS1 | OPA3 | OPALIN | OPCML | OPHN1 | Opioid receptor | OPLAH | OPN1LW | OPN1MW | OPN1MW3 | OPN1SW | OPN3 | OPN4 | OPN5 | OPRD1 | OPRK1 | OPRL1 | OPRM1 | OPRPN | OPTC | OPTN | OR10A2 | OR10A3 | OR10A4 | OR10A5 | OR10A6 | OR10A7 | OR10AA1P | OR10AB1P | OR10AC1 | OR10AD1 | OR10AF1P | OR10AG1 | OR10AK1P | OR10C1 | OR10D1P | OR10D3 | OR10D4P | OR10G2 | OR10G3 | OR10G4 | OR10G7 | OR10G8 | OR10G9 | OR10H1 | OR10H2 | OR10H3 | OR10H4 | OR10H5 | OR10J1 | OR10J2P | OR10J3 | OR10J5 | OR10K1 | OR10K2 | OR10P1 | OR10Q1 | OR10R2 | OR10S1 | OR10T2 | OR10V1 | OR10W1 | OR10X1 | OR10Z1 | OR11A1 | OR11G2 | OR11H1 | OR11H12 | OR11H13P | OR11H2 | OR11H5P | OR11H6 | OR11H7 | OR11J2P | OR11J5P | OR11K2P | OR11L1 | OR11M1P | OR12D2 | OR12D3 | OR13A1 | OR13C2 | OR13C3 | OR13C4 | OR13C5 | OR13C8 | OR13C9 | OR13D1 | OR13F1 | OR13G1 | OR13H1 | OR13J1 | OR13Z2P
